# Bio Green Med Solution, Inc.: overview BGMS · Nasdaq · CIK 1130166 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/bgms.md) · [Financials](/companies/bgms/financials.md) · [Filings](/companies/bgms/filings.md) · [Insiders](/companies/bgms/insiders.md) Latest reported revenue: [$336.0k](/filings/0001493152-26-038393.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 14, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax, accession 0001493152-26-038393). ## Last eight quarters | Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $k | [10.0](/filings/0001493152-25-022388.md) | [0.0 d](/filings/0001493152-26-013669.md) | not reported | not reported | [81.0](/filings/0001493152-25-022388.md) | [(81.0) d](/filings/0001493152-26-013669.md) | [743](/filings/0001493152-26-023800.md) | [336](/filings/0001493152-26-038393.md) | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | [(21770.0%)](/filings/0001493152-25-022388.md) | not reported | not reported | not reported | [(1224.7%)](/filings/0001493152-25-022388.md) | [1335.8% d](/filings/0001493152-26-013669.md) | [(33.1%)](/filings/0001493152-26-023800.md) | [(124.4%)](/filings/0001493152-26-038393.md) | | Net margin | % | [(19570.0%)](/filings/0001493152-25-022388.md) | not reported | not reported | not reported | [(1219.8%)](/filings/0001493152-25-022388.md) | [754.3% d](/filings/0001493152-26-013669.md) | [(26.5%)](/filings/0001493152-26-038393.md) | [(120.5%)](/filings/0001493152-26-038393.md) | | Diluted EPS | $ per share | [(43.80)](/filings/0001493152-25-022388.md) | not reported | [0.00](/filings/0001641172-25-010270.md) | [(0.98)](/filings/0001641172-25-023648.md) | [(1.31)](/filings/0001493152-25-022388.md) | not reported | not reported | not reported | | Free cash flow | $k | [(3,067) d](/filings/0001493152-25-022388.md) | not reported | not reported | not reported | not reported | not reported | [(279)](/filings/0001493152-26-023800.md) | [(352) d](/filings/0001493152-26-038393.md) | - Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure. ## Last five fiscal years | Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [0.0](/filings/0001558370-23-019369.md) | [0.0](/filings/0001558370-24-003713.md) | [0.4](/filings/0001493152-25-025179.md) | [0.0](/filings/0001493152-26-013669.md) | [0.0](/filings/0001493152-26-013669.md) | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | not reported | not reported | [(6060.2%)](/filings/0001493152-25-025179.md) | [(27916.3%)](/filings/0001493152-26-013669.md) | not reported | | Net margin | % | not reported | not reported | [(5370.2%)](/filings/0001493152-25-025179.md) | [(26074.4%)](/filings/0001493152-26-013669.md) | not reported | | Diluted EPS | $ per share | [(2.09)](/filings/0001558370-23-019369.md) | [(27.24)](/filings/0001558370-24-003713.md) | [(6419.18)](/filings/0001493152-25-025179.md) | [(502.46)](/filings/0001493152-26-013669.md) | [(6.45)](/filings/0001493152-26-013669.md) | | Free cash flow | $m | [(18.6)](/filings/0001558370-23-019369.md) | [(20.8)](/filings/0001558370-24-003713.md) | [(16.1)](/filings/0001493152-25-025179.md) | not reported | not reported | - Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax; Revenue: us-gaap:Revenues. - Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax; Revenue: us-gaap:Revenues. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax; Revenue: us-gaap:Revenues. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax; Revenue: us-gaap:Revenues. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/bgms/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [CITADEL ADVISORS LLC](/funds/1423053.md) | 2026-06-30 | $68.5k | 75,240 | | Added +53,189 | | [JANE STREET GROUP, LLC](/funds/1595888.md) | 2026-06-30 | $14.8k | 16,291 | | New +16,291 | | [Tower Research Capital LLC (TRC)](/funds/1533421.md) | 2026-06-30 | $5.2k | 5,722 | | Added +1,461 | | [UBS Group AG](/funds/1610520.md) | 2026-06-30 | $3.9k | 4,332 | | Added +2,163 | | [SBI Securities Co., Ltd.](/funds/1851815.md) | 2026-06-30 | $638 | 701 | | Added +201 | | [Archer Investment Corp](/funds/1803804.md) | 2026-06-30 | $1 | 1 | | Unchanged | | [Archer Investment Corp](/funds/1803804.md) | 2026-06-30 | $1 | 1 | | Unchanged | | [OSAIC HOLDINGS, INC.](/funds/1677044.md) | 2026-06-30 | $0 | 1 | | Unchanged | ## Recent filings [All 1,053 filings](/companies/bgms/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-10-16 | 20:05 ET | [8-K](/filings/0001493152-26-047396.md) | 8.01 Other events | 0001493152-26-047396 | | 2026-08-14 | 20:16 ET | [10-Q](/filings/0001493152-26-038393.md) | Quarterly report, period 2026-06-30 | 0001493152-26-038393 | | 2026-08-14 | 01:37 ET | [8-K](/filings/0001493152-26-037902.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-037902 | | 2026-07-01 | 20:05 ET | [8-K](/filings/0001493152-26-031542.md) | 8.01 Other events | 0001493152-26-031542 | | 2026-06-22 | 10:10 ET | [8-K](/filings/0001493152-26-029452.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001493152-26-029452 | | 2026-06-10 | 16:47 ET | [8-K](/filings/0001493152-26-028072.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-26-028072 | | 2026-06-04 | 20:45 ET | [8-K](/filings/0001493152-26-027291.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-027291 | | 2026-05-15 | 20:16 ET | [10-Q](/filings/0001493152-26-023800.md) | Quarterly report, period 2026-03-31 | 0001493152-26-023800 | | 2026-05-14 | 20:25 ET | [8-K](/filings/0001493152-26-023117.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-023117 | | 2026-04-27 | 20:38 ET | [DEF 14A](/filings/0001493152-26-019158.md) | Proxy statement, period 2026-04-27 | 0001493152-26-019158 | ## Latest annual report [Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001493152-26-013669.md), filed Mar 30, 2026. ## Forecast league Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/f1708017-2780-4f02-b857-991669bb8ac8) ## About the filer - CIK: 1130166 - Tickers: BGMS, BGMSP - Exchange: Nasdaq - SIC code: 5099 Wholesale-Durable Goods, NEC - State of incorporation: DE - Filer category: Non-accelerated filer
Smaller reporting company Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:34 ET. No prices; not investment advice.